Presentation Information
[27-19-pm10S]Comparison of the effects of combining SGLT2 inhibitors with DPP-4 inhibitors versus switching to GLP-1 receptor agonists in patients on DPP-4 inhibitors.
○Masaki Chikushi1, Taichi Muramatsu1, Takako Kikuchi2, Ryosuke Kumazawa1, Ryoko Sakai1, Akifumi Kushiyama1, Manabu Akazawa1 (1. Meiji Pharmaceutical University, 2. The Institute of Medical Science, Asahi Life Foundation)